Diabetes technology

Comparing the glycaemic outcomes between real‐time continuous glucose monitoring ( rt‐CGM ) and intermittently scanned continuous glucose monitoring ( intermittently scanned continuous glucose monitoring (isCGM) ) among adults and children with type 1 diabetes: A systematic review and meta‐analysis of randomized controlled trials

Diabet MedPublished Systematic review and meta-analysis of randomised trials

Pooled result · Absolute TIR; HbA1cResult — go to the resultMD +7.0 % 95% CI 5.8%–8.3%

Authors' conclusion

This meta-analysis highlights that for people with T1D, rtCGM confers benefits over isCGM primarily related to increased TIR, with improvements in hypo- and hyperglycaemia.

Study context

Population
People with T1D of any age and insulin regimen; 354 adults, 92 children and adolescents
Participants
446 people5 randomized controlled trials (RCTs)
Comparison
Real-time continuous glucose monitoring (rtCGM) vs isCGM
Outcome
Co-primary: HbA1c and TIR 70-180 mg/dL (3.9-10.0 mmol/L)
Follow-up
Post-intervention
Methodological detailsrandom-effect meta-analysis, Cochrane RoB2, GRADE, 4 parallel and 1 crossover RCT; 4 with CGM use <8 weeks
  • Random-effect meta-analysis
  • Cochrane RoB2
  • GRADE
  • 4 parallel and 1 crossover RCT; 4 with CGM use <8 weeks

Pooled result

Absolute TIR; HbA1c

MD

+7.0 %

95% CI 5.8%–8.3%

P < 0.01

As reported in the abstract

Further pooled results

OutcomeMD (%) (95% CI)P value
Time-below-range <70 mg/dL (3.9 mmol/L) · post-intervention- 1.7 (−3.0% to −0.4%)P = 0.03

Original publication

Comparing the glycaemic outcomes between real‐time continuous glucose monitoring ( rt‐CGM ) and intermittently scanned continuous glucose monitoring ( isCGM ) among adults and children with type 1 diabetes: A systematic review and meta‐analysis of randomized controlled trials. Diabet Med. Published 10 January 2024. doi:10.1111/dme.15280

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.